Optimization of Management in Patients With Cardiovascular Disease After Lower Limb Joint Replace… (NCT06627933) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Optimization of Management in Patients With Cardiovascular Disease After Lower Limb Joint Replacement
Russia1,733 participantsStarted 2023-01-15
Plain-language summary
The goal of the study is to evaluate the frequency of cardiovascular and thromboembolic complications in patients with cardiovascular disease after lower limb joint replacement, the influence of known risk factors and strategies for perioperative prevention of thromboembolic complications on the frequency of cardiovascular complications and to develop approaches to optimize antithrombotic prevention tactics.
Who can participate
Age range
18 Years – 95 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Informed consent
* Age older than 18 y.o.
* Cardiovascular disease
* Indications for planned lower limb joint replacement surgery
Exclusion Criteria:
* Pregnancy
* Psychiatric disorders
* Decompensated heart failure or acute heart failure
* Known diagnosis of cancer
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Bleeding
Timeframe: 1 month
2
Bleeding
Timeframe: 3 months
3
Bleeding
Timeframe: 6 months
4
Thromboembolism
Timeframe: 1 month
5
Thromboembolism
Timeframe: 3 months
6
Thromboembolism
Timeframe: 6 months
Trial details
NCT IDNCT06627933
SponsorI.M. Sechenov First Moscow State Medical University